Neuroblastoma is commonly associated with genomic abnormalities including MYCN amplification (~ 25–35%; Chr 2p), 1p and 11q loss as well as 17q gain, the most frequent (> 50%) chromosomal aberration [1–4]. Here, MYCN is linked to neuroblastoma.